NO20023448L - Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin - Google Patents
Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapinInfo
- Publication number
- NO20023448L NO20023448L NO20023448A NO20023448A NO20023448L NO 20023448 L NO20023448 L NO 20023448L NO 20023448 A NO20023448 A NO 20023448A NO 20023448 A NO20023448 A NO 20023448A NO 20023448 L NO20023448 L NO 20023448L
- Authority
- NO
- Norway
- Prior art keywords
- depression
- treatment
- related disorders
- drug combination
- disorders including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200189 | 2000-01-19 | ||
PCT/EP2001/000407 WO2001052855A2 (fr) | 2000-01-19 | 2001-01-15 | Association de medicaments pour le traitement de depressions et de troubles s'y rapportant, comprenant de la mirtazapine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20023448D0 NO20023448D0 (no) | 2002-07-18 |
NO20023448L true NO20023448L (no) | 2002-09-17 |
Family
ID=8170928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20023448A NO20023448L (no) | 2000-01-19 | 2002-07-18 | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin |
Country Status (21)
Country | Link |
---|---|
US (2) | US6835728B2 (fr) |
EP (1) | EP1251854A2 (fr) |
JP (1) | JP2003520237A (fr) |
KR (1) | KR20020068404A (fr) |
CN (1) | CN1223349C (fr) |
AR (1) | AR027240A1 (fr) |
AU (1) | AU780817B2 (fr) |
BR (1) | BR0107721A (fr) |
CA (1) | CA2396066A1 (fr) |
CO (1) | CO5261583A1 (fr) |
HK (1) | HK1047548A1 (fr) |
HU (1) | HUP0204050A3 (fr) |
IL (1) | IL150289A0 (fr) |
MX (1) | MXPA02007095A (fr) |
NO (1) | NO20023448L (fr) |
PE (1) | PE20011049A1 (fr) |
PL (1) | PL356605A1 (fr) |
RU (1) | RU2268725C2 (fr) |
SK (1) | SK10552002A3 (fr) |
WO (1) | WO2001052855A2 (fr) |
ZA (1) | ZA200205161B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
US20060039867A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders with setiptiline |
US20060122127A1 (en) * | 2004-11-17 | 2006-06-08 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtzapine treatment |
GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
PE20070523A1 (es) | 2005-09-12 | 2007-06-28 | Wyeth Corp | Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona |
EP1792618A1 (fr) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine pour le traitement de la douleur |
KR20090024140A (ko) * | 2006-05-22 | 2009-03-06 | 반다 파마슈티칼즈, 인코퍼레이티드. | 우울증 질환에 대한 치료 |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
EP2167096A4 (fr) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | Amélioration de la tolérance à la mirtazapine et à un second principe actif par utilisation combinée de ces derniers |
AU2008318284B2 (en) * | 2007-11-02 | 2012-03-22 | Acrux Dds Pty Ltd | Transdermal delivery system |
CN102918031A (zh) | 2010-05-28 | 2013-02-06 | 通用电气健康护理有限公司 | 放射标记的化合物及其方法 |
GB201112987D0 (en) | 2011-07-28 | 2011-09-14 | Ge Healthcare Ltd | Novel compound |
CN108743593B (zh) * | 2018-08-31 | 2019-03-26 | 程世宏 | 一种抗抑郁药物及其口服颗粒剂和制药用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US5011841B1 (en) * | 1989-11-14 | 1994-09-06 | Pfizer | Treatment of depression |
GB9303968D0 (en) * | 1993-02-26 | 1993-04-14 | Wyeth John & Brother Ltd | 5-ht1a ligands |
GB9603136D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
ZA982368B (en) * | 1997-03-27 | 1998-09-23 | Akzo Nobel Nv | New therapeutic combinations |
IL123716A (en) | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
-
2001
- 2001-01-15 PL PL01356605A patent/PL356605A1/xx not_active Application Discontinuation
- 2001-01-15 IL IL15028901A patent/IL150289A0/xx unknown
- 2001-01-15 EP EP01900449A patent/EP1251854A2/fr not_active Withdrawn
- 2001-01-15 BR BR0107721-0A patent/BR0107721A/pt not_active IP Right Cessation
- 2001-01-15 CA CA002396066A patent/CA2396066A1/fr not_active Abandoned
- 2001-01-15 US US10/181,843 patent/US6835728B2/en not_active Expired - Fee Related
- 2001-01-15 WO PCT/EP2001/000407 patent/WO2001052855A2/fr not_active Application Discontinuation
- 2001-01-15 HU HU0204050A patent/HUP0204050A3/hu unknown
- 2001-01-15 SK SK1055-2002A patent/SK10552002A3/sk not_active Application Discontinuation
- 2001-01-15 JP JP2001552902A patent/JP2003520237A/ja not_active Withdrawn
- 2001-01-15 AU AU25162/01A patent/AU780817B2/en not_active Ceased
- 2001-01-15 KR KR1020027009276A patent/KR20020068404A/ko not_active Application Discontinuation
- 2001-01-15 RU RU2002122084/15A patent/RU2268725C2/ru not_active IP Right Cessation
- 2001-01-15 MX MXPA02007095A patent/MXPA02007095A/es not_active Application Discontinuation
- 2001-01-15 CN CNB018038654A patent/CN1223349C/zh not_active Expired - Fee Related
- 2001-01-18 CO CO01003479A patent/CO5261583A1/es not_active Application Discontinuation
- 2001-01-18 PE PE2001000055A patent/PE20011049A1/es not_active Application Discontinuation
- 2001-01-18 AR ARP010100214A patent/AR027240A1/es not_active Application Discontinuation
-
2002
- 2002-06-27 ZA ZA200205161A patent/ZA200205161B/en unknown
- 2002-07-18 NO NO20023448A patent/NO20023448L/no not_active Application Discontinuation
- 2002-12-18 HK HK02109168.5A patent/HK1047548A1/zh unknown
-
2004
- 2004-11-22 US US10/996,213 patent/US20050090488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR027240A1 (es) | 2003-03-19 |
RU2002122084A (ru) | 2004-03-10 |
SK10552002A3 (sk) | 2002-12-03 |
BR0107721A (pt) | 2002-10-01 |
AU780817B2 (en) | 2005-04-21 |
HUP0204050A2 (hu) | 2003-03-28 |
US6835728B2 (en) | 2004-12-28 |
PL356605A1 (en) | 2004-06-28 |
US20050090488A1 (en) | 2005-04-28 |
CO5261583A1 (es) | 2003-03-31 |
WO2001052855A8 (fr) | 2002-12-27 |
CN1395486A (zh) | 2003-02-05 |
WO2001052855A3 (fr) | 2002-01-10 |
WO2001052855A2 (fr) | 2001-07-26 |
US20030105083A1 (en) | 2003-06-05 |
NO20023448D0 (no) | 2002-07-18 |
CN1223349C (zh) | 2005-10-19 |
CA2396066A1 (fr) | 2001-07-26 |
AU2516201A (en) | 2001-07-31 |
PE20011049A1 (es) | 2001-10-18 |
IL150289A0 (en) | 2002-12-01 |
HUP0204050A3 (en) | 2004-09-28 |
JP2003520237A (ja) | 2003-07-02 |
ZA200205161B (en) | 2003-09-29 |
HK1047548A1 (zh) | 2003-02-28 |
EP1251854A2 (fr) | 2002-10-30 |
MXPA02007095A (es) | 2003-04-14 |
KR20020068404A (ko) | 2002-08-27 |
RU2268725C2 (ru) | 2006-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
DE60142473D1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
NO20021845D0 (no) | Behandling av sövnforstyrrelser under anvendelse av desloratadin | |
ATE286028T1 (de) | Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen | |
NO20022680L (no) | Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser | |
EE200200442A (et) | Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks | |
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20043085L (no) | Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet | |
NO20023448L (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
NO20032636D0 (no) | 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
IS6137A (is) | Meðhöndlun á hugsýkistruflunum | |
NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
IL158704A0 (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
NO20024776L (no) | Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte | |
NO20024777D0 (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
ZA200309513B (en) | Novel heterocyclic derivatives and medicinal use thereof. | |
IL158703A0 (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
NO20023803L (no) | Anvendelse av mirtazapin for behandling av sövnforstyrrelser | |
NO20032156D0 (no) | Behandling av angstforstyrrelser | |
IL158632A0 (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
NO20032006L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser | |
IL158695A0 (en) | 4-(phenyl-piperidin-4-yldine-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |